Table 3.
Univariate and Multivariable Logistic Regression Analysis of Predictive Factors for VETC in the Training Cohort.
| Parameter | Univariate | Multivariable | ||
|---|---|---|---|---|
| OR (95% CI) | P-Value | OR (95% CI) | P-Value | |
| LMR | ||||
| ≤7.75 | Reference | |||
| >7.75 | 3.49 (1.17–10.41) | .025 | 4.06 (1.14–14.48) | .031 |
| PLR | ||||
| ≤40 | Reference | |||
| >40 | 2.003 (1.02–3.91) | .042 | 2.32 (.98–5.48) | .056 |
| Neutrophil | ||||
| ≤7 | Reference | |||
| >7 | 2.684 (.95–7.56) | .062 | 4.48 (1.20–16.70) | .025 |
| AAR | ||||
| ≤.86 | Reference | |||
| >.86 | 1.77 (.95–3.31) | .075 | 2.16 (1.00–4.64) | .049 |
| ALRI | ||||
| ≤29.75 | Reference | |||
| >29.75 | 1.87 (.99–3.54) | .052 | .71 (.25–2.00) | .513 |
| ANRI | ||||
| ≤12.43 | Reference | |||
| >12.43 | 1.74 (.95–3.17) | .073 | 1.18 (.51–2.70) | .698 |
| APRI | ||||
| ≤.21 | Reference | |||
| >.21 | 1.51 (.84–2.74) | .171 | ||
| BLRI | ||||
| ≤21.73 | Reference | |||
| >21.73 | 1.78 (.98–3.24) | .059 | 2.58 (1.04–6.37) | .042 |
| SII | ||||
| ≤545.6 | Reference | |||
| >545.6 | 1.50 (.80–2.83) | .208 | ||
| AFP(ln) | 1.14 (1.04–1.24) | .004 | 1.10 (1.00–1.22) | .046 |
| Tumor diameter (ln) | 3.77 (2.05–6.92) | <.0001 | 2.65 (1.36–5.16) | .004 |
OR: Odds ratio; LMR: lymphocyte to monocyte ratio; PLR: platelet-lymphocyte ratio; AAR: AST to ALT ratio; ALRI: AST to lymphocyte ratio index; ANRI: AST to neutrophil ratio index; APRI: AST to platelet ratio index; BLRI: ALT to lymphocyte ratio index; SII: systemic immune-inflammation index.